• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

范可尼贫血患者首次不良事件的个体化风险

Individualized risks of first adverse events in patients with Fanconi anemia.

作者信息

Rosenberg Philip S, Huang Yi, Alter Blanche P

机构信息

Biostatistics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, 6120 Executive Blvd, Executive Plaza South, Rm 7006, Rockville, MD 20852-7244, USA.

出版信息

Blood. 2004 Jul 15;104(2):350-5. doi: 10.1182/blood-2004-01-0083. Epub 2004 Apr 1.

DOI:10.1182/blood-2004-01-0083
PMID:15059844
Abstract

Fanconi anemia (FA) is an autosomal recessive condition associated with bone marrow failure (BMF) leading to death or hematopoietic stem cell transplantation, acute myeloid leukemia (AML), and solid tumors (STs). It is unclear which patients are most likely to develop each outcome. From a cohort of 144 North American patients with FA, we calculated individualized risks of each outcome, given the presence or absence of readily diagnosed congenital abnormalities that occur frequently in FA. Abnormal radii and a 5-item congenital abnormality score were significant risk factors for BMF. The cumulative incidence of BMF by age 10 years varied from 18% in the lowest BMF risk group to 83% in the highest. Because of competing risks, patients in the lowest BMF risk group were most likely to live long enough to develop AML or ST, and, conversely, patients in the highest BMF risk group were least likely to live long enough to develop AML or ST. By age 40, the cumulative incidence of ST ranged from 0.6% to 29% in the highest and lowest BMF risk groups, respectively. Abnormal radii are the strongest predictor of early BMF in FA; a congenital abnormality score separates patients with normal radii into distinct prognostic groups.

摘要

范可尼贫血(FA)是一种常染色体隐性疾病,与骨髓衰竭(BMF)相关,可导致死亡或需要进行造血干细胞移植,还与急性髓系白血病(AML)和实体瘤(STs)有关。目前尚不清楚哪些患者最有可能出现每种结局。在一组144例北美FA患者中,我们根据是否存在FA中常见的易于诊断的先天性异常,计算了每种结局的个体化风险。桡骨异常和一项包含5项内容的先天性异常评分是BMF的显著危险因素。10岁时BMF的累积发病率在最低BMF风险组为18%,在最高风险组为83%。由于存在竞争风险,最低BMF风险组的患者最有可能存活足够长的时间以发展为AML或ST,相反,最高BMF风险组的患者存活足够长的时间以发展为AML或ST的可能性最小。到40岁时,最高和最低BMF风险组中ST的累积发病率分别为0.6%至29%。桡骨异常是FA早期BMF的最强预测指标;先天性异常评分将桡骨正常的患者分为不同的预后组。

相似文献

1
Individualized risks of first adverse events in patients with Fanconi anemia.范可尼贫血患者首次不良事件的个体化风险
Blood. 2004 Jul 15;104(2):350-5. doi: 10.1182/blood-2004-01-0083. Epub 2004 Apr 1.
2
Cancer risks in Fanconi anemia: findings from the German Fanconi Anemia Registry.范可尼贫血的癌症风险:来自德国范可尼贫血登记处的研究结果。
Haematologica. 2008 Apr;93(4):511-7. doi: 10.3324/haematol.12234. Epub 2008 Mar 5.
3
Cancer incidence in persons with Fanconi anemia.范可尼贫血患者的癌症发病率。
Blood. 2003 Feb 1;101(3):822-6. doi: 10.1182/blood-2002-05-1498. Epub 2002 Sep 5.
4
Preemptive Bone Marrow Transplantation and Event-Free Survival in Fanconi Anemia.范可尼贫血的抢先性骨髓移植与无事件生存期
Biol Blood Marrow Transplant. 2016 Oct;22(10):1888-1892. doi: 10.1016/j.bbmt.2016.06.018. Epub 2016 Jun 21.
5
Aberrant Fanconi anaemia protein profiles in acute myeloid leukaemia cells.急性髓系白血病细胞中异常的范可尼贫血蛋白谱
Br J Haematol. 2000 Dec;111(4):1057-64.
6
A 20-year perspective on the International Fanconi Anemia Registry (IFAR).国际范可尼贫血登记处(IFAR)20年展望。
Blood. 2003 Feb 15;101(4):1249-56. doi: 10.1182/blood-2002-07-2170. Epub 2002 Sep 26.
7
Fanconi anaemia: A syndrome with distinct subgroups.范可尼贫血:具有不同亚组的综合征。
Br J Haematol. 2022 May;197(4):467-474. doi: 10.1111/bjh.18091. Epub 2022 Feb 22.
8
Genotype-phenotype and outcome associations in patients with Fanconi anemia: the National Cancer Institute cohort.范可尼贫血患者的基因型-表型和结局关联:美国国家癌症研究所队列研究。
Haematologica. 2023 Jan 1;108(1):69-82. doi: 10.3324/haematol.2021.279981.
9
Fanconi anemia and the development of leukemia.范可尼贫血与白血病的发生
Best Pract Res Clin Haematol. 2014 Sep-Dec;27(3-4):214-21. doi: 10.1016/j.beha.2014.10.002. Epub 2014 Oct 15.
10
Leukemia and preleukemia in Fanconi anemia patients. A review of the literature and report of the International Fanconi Anemia Registry.范可尼贫血患者中的白血病和白血病前期。文献综述及国际范可尼贫血登记处报告
Cancer Genet Cytogenet. 1991 Jan;51(1):1-12. doi: 10.1016/0165-4608(91)90002-c.

引用本文的文献

1
Longitudinal clinical manifestations of Fanconi anemia: A systematized review.范可尼贫血的纵向临床特征:系统综述。
Blood Rev. 2024 Nov;68:101225. doi: 10.1016/j.blre.2024.101225. Epub 2024 Aug 2.
2
Benign tumors and non-melanoma skin cancers in patients with Fanconi anemia.范可尼贫血患者中的良性肿瘤和非黑素瘤皮肤癌。
Fam Cancer. 2024 Nov;23(4):583-590. doi: 10.1007/s10689-024-00410-2. Epub 2024 Jun 21.
3
Deregulated protein homeostasis constrains fetal hematopoietic stem cell pool expansion in Fanconi anemia.蛋白稳态失调限制范可尼贫血症胎儿造血干细胞库的扩增。
Nat Commun. 2024 Feb 29;15(1):1852. doi: 10.1038/s41467-024-46159-1.
4
Fanconi anemia phenotypic and transplant outcomes' associations in Iranian patients.伊朗患者中范可尼贫血的表型与移植结果的关联
Health Sci Rep. 2023 Apr 5;6(4):e1180. doi: 10.1002/hsr2.1180. eCollection 2023 Apr.
5
Two decades of stem cell transplantation in patients with Fanconi anemia: Analysis of factors affecting transplant outcomes.二十年来范可尼贫血患者的干细胞移植:影响移植结果的因素分析。
Clin Transplant. 2023 Jan;37(1):e14835. doi: 10.1111/ctr.14835. Epub 2022 Nov 23.
6
Next-generation sequencing reveals novel variants and large deletion in FANCA gene in Polish family with Fanconi anemia.下一代测序揭示了波兰范可尼贫血症家系 FANCA 基因中的新型变异和大片段缺失。
Orphanet J Rare Dis. 2022 Jul 19;17(1):282. doi: 10.1186/s13023-022-02424-4.
7
Metformin for treatment of cytopenias in children and young adults with Fanconi anemia.二甲双胍治疗范可尼贫血儿童和青年的血细胞减少症。
Blood Adv. 2022 Jun 28;6(12):3803-3811. doi: 10.1182/bloodadvances.2021006490.
8
Cell senescence and malignant transformation in the inherited bone marrow failure syndromes: Overlapping pathophysiology with therapeutic implications.遗传性骨髓衰竭综合征中的细胞衰老和恶性转化:具有治疗意义的重叠病理生理学。
Semin Hematol. 2022 Jan;59(1):30-37. doi: 10.1053/j.seminhematol.2022.01.003. Epub 2022 Jan 31.
9
Genotype-phenotype and outcome associations in patients with Fanconi anemia: the National Cancer Institute cohort.范可尼贫血患者的基因型-表型和结局关联:美国国家癌症研究所队列研究。
Haematologica. 2023 Jan 1;108(1):69-82. doi: 10.3324/haematol.2021.279981.
10
An update on Fanconi anemia: Clinical, cytogenetic and molecular approaches (Review).范可尼贫血的最新进展:临床、细胞遗传学和分子学方法(综述)
Biomed Rep. 2021 Sep;15(3):74. doi: 10.3892/br.2021.1450. Epub 2021 Jul 15.